top of page




PROFESSOR EMIN EVREN ÖZCAN, M.D., PH.D., FEHRA is the director of DEU Heart Rhythm Management Center, Izmir, Turkey. He is an European Heart Rhythm Association Certified Electrophysiology Specialist since 2014. Besides his intense clinical experience exceeding 400 cases per year, he conducts many structured international trainings.

Dr. Özcan has many active roles in international organizations. He is a member of EHRA Certification Committee since 2017 and he is a board member of Silk Road Heart Rhythm Association, which has been working for the dissemination of arrhythmia treatment in Central Asian Countries. He was the national ambassador of Turkey in the EHRA Young Electrophysiologists Committee (2013-2017).


Medical Education: Ankara University, Faculty of Medicine, Ankara, Turkey (1994-2000)

Cardiology Training: Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey (2001-2006)

Clinical Electrophysiology fellowship, European Society of Cardiology Heart Rhythm Association fellow, Semmelweis University Heart Center, Budapest, Hungary (2011-2013)

PhD: Non-pharmacological techniques of antiarrhythmic therapy.Semmelweis University, School of PhD, Budapest, Hungary (2013-2017)

Associate Prof. of Cardiology, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey (2015)

Diploma of Advanced Studies in Cardiac Arrhythmia Management, Maastricht University, Netherlands (2019- 2021)

Fellow of the European Heart Rhythm Association (FEHRA) 2021

Member of the Research and Development Projects Evaluation Commission, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey (2021)

Professor of Cardiology, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey (2022)


European Heart Rhythm Association Certified Electrophysiology Specialist  - January 2014


European Heart Rhythm Association Certification Committee Member (2017-)

Turkish Ambassador in EHRA Young Electrophysiologists Committee (2013-2017)

Silk Road Heart Rhythm Society Board Member (2017-)


European Society of Cardiology Heart Rhythm Association

American College of Cardiology

Turkish Society of Cardiology

Hungarian Society of Cardiology


European Heart Rhythm Association –EHRA- Two years Basic Clinical Electrophysiology Fellowship Madrid –Spain – 2011

European Heart Rhythm Association –EHRA- Proctorship Award – Heart Rhythm Management Center UZ Brussels – Belgium – April 2015

EHRA Europace Congress Best Case Presentation Award – Milan – Italy – June 2015

EHRA Cardiostim Congress Best Case Presentation Award – Vienna – Austria– June 2017


Theoretical and hands on training on electrophysiology and cardiac pacing, Dokuz Eylül University, Izmir, Turkey

3D mapping and ablation trainings on alive animal model, European Surgical Institute, Hamburg, Germany.

Fundamentals of Cardiac Electrophysiology Training, Medtronic Innovation Center, Istanbul

Arrhythima and cardiac electrophysiology Lectures for 3rd,4th and 6thyear medical students in Dokuz Eylül University, Izmir, Turkey.


Cumulative IF: 123.39

Citations: 821

h-index: 13

Publications in peer reviewed journals: 64 (62 in international journals, 2 in national journals)

Book Chapters: 6 (1 international, 5 national)

Translation Editor: 1 book  Handbook of Cardiac Electrophysiology: Edited by Andrea Natale, Informa Healthcare publishing. Turkish translation: Ozcan EE, Translation editors: Ozcan EE, Kozan O. İstanbul: Gunes Publishing; 2010

Reviewer: BMJ Case reports, Anatolian Journal of Cardiology, Archives of the Turkish Society of Cardiology, Northern Clinics of Istanbul, Hellenic Journal of Cardiology, Frontiers in Cardiovascular Medicine.

1. Ekrem Turan O, Yilancioğlu RY, İnevi U, Özcan EE. Pre-procedural imaging and atrial tachycardia ablation in a patient with complex congenital heart disease. Pacing Clin Electrophysiol. 2023 Jan 28. doi: 10.1111/pace.14664 IF: 1.91

2. Yilancioglu RY, Turan OE, Başkurt AA, Özcan EE. Lead related atrial perforation mimicking inferior ST elevation myocardial infarction. Pacing Clin Electrophysiol. 2022 Dec 7. doi: 10.1111/pace.14641. IF: 1.91

3. Doğduş M, Turan OE, Başkurt AA, Yılancıoğlu RY, Özgül U, İnevi UD, Özcan EE. Answer Regarding P Wave Index and Atrial Fibrillation Recurrence. Turk Kardiyol Dern Ars. 2022 Dec;50(8):623. doi: 10.5543/tkda.2022.2263622.

4. Ozgul U, Turan OE, Baskurt AA, Yilancioglu RY, Dogdus M, Inevi UD, Ozcan EE. The predictive value of electrocardiographic polarization parameters on appropriate ICD shock in primary prevention heart failure patients. J Electrocardiol. 2022 Nov 5:S0022-0736(22)00200-X. doi: 10.1016/j.jelectrocard.2022.10.008. IF: 1.38

5. Dogdus M, Dindas F, Turan OE, Yilancioglu RY, Ozgul U, Inevi UD, Ozcan EE. Evaluation of left atrial and left ventricular functions in patients with Wolff-Parkinson-White syndrome before and after radiofrequency catheter ablation using three-dimensional speckle tracking echocardiography. Echocardiography. 2022 Dec;39(12):1488-1495. doi: 10.1111/echo.15473. IF: 1.87

6. Stühlinger M, Burri H, Vernooy K, Garcia R, Lenarczyk R, Sultan A, Brunner M, Sabbag A, Özcan EE, Ramos JT, Di Stolfo G, Suleiman M, Tinhofer F, Aristizabal JM, Cakulev I, Eidelman G, Yeo WT, Lau DH, Mulpuru SK, Nielsen JC; ESC Scientific Document Group:; Heinzel F, Prabhu M, Rinaldi CA, Sacher F, Guillen R, de Pooter J, Gandjbakhch E, Sheldon S, Prenner G, Mason PK, Fichtner S, Nitta T. EHRA consensus on prevention and management of interference due to medical procedures in patients with cardiac implantable electronic devices. Europace. 2022 Oct 13;24(9):1512-1537. doi: 10.1093/europace/euac040. IF: 5.48

7. Doğduş M, Turan OE, Başkurt AA, Yılancıoğlu RY, Özgül U, İnevi UD, Özcan EE. An Effective Novel Index for Predicting the Recurrence of Atrial Fibrillation Ablation: P Wave Duration-to-Amplitude Ratio. Turk Kardiyol Dern Ars. 2022 Oct;50(7):498-504. doi: 10.5543/tkda.2022.22416.

8. Ozcan EE, Dogdus M, Yilancioglu RY, Adiyaman SC, Turan OE. Invasive Heart Rate Control as a Salvage Therapy in Amiodarone-induced Thyroid Storm. Medeni Med J.  2022 Mar 18;37(1):119-122. doi:10.4274/MMJ.galenos.2022.55453.

9. Yalin K, Ikitimur B, Aksu T, Ozcan EE, Ding WY, Soysal AU, Lyan E, Eitel C, Saygi S, Turan OE, Hegeer CH, Tilz RR, Gupta D. Catheter Ablation for Atrial Fibrillation in Patients ≤30 Years of Age. Am J Cardiol. 2022 Mar 1;166:53-57. doi: 10.1016/j.amjcard.2021.11.020. Epub 2021 Dec 30. IF: 3.13

10. Ozcan EE, Yilancioglu RY, Inevi UD, Gurel D, Dogdus M. Should add-hoc cardiac biopsy be routine in patients with cardiomyopathy of unknown etiology undergoing electrical storm ablation? Pacing Clin Electrophysiol. 2022 Apr;45(4):578-580. doi: 10.1111/pace.14432. Epub 2022 Jan 13. IF: 1.91

11. Turan OE, Yilancioglu RY, Baskurt AA, Ozcan EE. An unusual 'bow tie' image in pacemaker implantation. Indian Pacing Electrophysiol J. 2022 Jan-Feb;22(1):51-53. doi: 10.1016/j.ipej.2021.10.007. IF: 0.58

12. Ozcan EE, Turan OE, Akdemir B, Inevi UD, Yilancioglu RY, Baskurt AA, Alak C, Bayrak F. Comparison of electrophysiological characteristics of right- and left-sided Mahaim-type accessory pathways. J Cardiovasc Electrophysiol. 2021 Feb;32(2):360-369. doi: 10.1111/jce.14852. IF: 2.42

13. Koçyiğit D, Sarıgül NU, Altın AT, Çay S, Polat V, Saygı S, Gümrükçüoğlu HA, Gemici K, İkitimur B, Akyol A, Bilge AK, Başarıcı İ, Özcan EE, Demir M, Kabul HK, Ornek E, Normand C, Linde C, Dickstein K. Current clinical practice of cardiac resynchronization therapy in Turkey: Reflections from Cardiac Resynchronization Therapy Survey-II. Anatol J Cardiol. 2020 Dec;24(6):382-396. doi: 10.14744/AnatolJCardiol.2020.02680. IF: 1.22

14. Torp-Pedersen C, Goette A, Nielsen PB, Potpara T, Fauchier L, John Camm A, Arbelo E, Boriani G, Skjoeth F, Rumsfeld J, Masoudi F, Guo Y, Joung B, Refaat MM, Kim YH, Albert CM, Piccini J, Avezum A, Lip GYH; External Reviewers: Gorenek B, Dagres N, Violi F, Du X, Akao M, Choi E, Lopes RD, Ozcan EE, Lane D, Marin F, Gale CP, Vernooy K, Kudaiberdieva G, Kutyifa V, Traykov VB, Guevara C, Chao T, Al-Khatib SM. Real-world' observational studies in arrhythmia research: data sources, methodology, and interpretation. A position document from European Heart Rhythm Association (EHRA), endorsed by Heart Rhythm Society (HRS), Asia-Pacific HRS (APHRS), and Latin America HRS (LAHRS). Europace. 2020;22:831-832. doi: 10.1093/europace/euz210 IF:5.04

15. Gorenek B, Fisher JD, Kudaiberdieva G, Baranchuk A, Burri H, Campbell KB, Chung MK, Enriquez A, Heidbuchel H, Kutyifa V, Krishnan K, Leclercq C, Ozcan EE, Patton KK, Shen W, Tisdale JE, Turagam MK, Lakkireddy D. Premature ventricular complexes: diagnostic and therapeutic considerations in clinical practice : A state-of-the-art review by the American College of Cardiology Electrophysiology Council. J Interv Card Electrophysiol. 2020;57:5-26. doi: 10.1007/s10840-019-00655-3. IF:1.53

16. Şimşek E, Özcan EE, Demir E, Öztürk P, Nalbatgil S. Ablation of ventricular tachycardia in a patient with a left ventricular assist device. Turk Kardiyol Dern Ars. 2020;48:58-63. doi: 10.5543/tkda.2019.06624.

17. Akdemir B, Zoltan S, Gellér L, Özcan EE. Challenging ablation of the left posterior accessory pathway due to aortic and mitral mechanical valves. J Cardiovasc Electrophysiol. 2019;30:2520-2522. doi: 10.1111/jce.14157. IF:2.91

18. Ozcan EE, Gorenek B. Corundum of stroke risk in atrial high rate episodes. J Cardiol. 2019;74:394. doi: 10.1016/j.jjcc.2019.03.020. IF:2.28

19. Özel E, Koşar MF, Ozcan EE, Hünük B, Ulus T, Aytekin V, Yildirir A, Özin B, Erdinler I, Akyürek Ö. Turkish Society of Cardiology consensus report on recommendations for athletes with high-risk genetic cardiovascular diseases or implanted cardiac devices. Anatol J Cardiol. 2019;22:140-151. doi: 10.14744/AnatolJCardiol.2019.09633. IF:1.11

20. Gellér L, Salló Z, Molnár L, Tahin T, Özcan EE, Kutyifa V, Osztheimer I, Szilágyi S, Szegedi N, Ábrahám P, Apor A, Nagy KV, Kosztin A, Becker D, Herczeg S, Zima E, Merkely B. Long-term single-centre large volume experience with transseptal endocardial left ventricular lead implantation. Europace. 2019;21:1237-1245. doi: 10.1093/europace/euz116. IF:6.10

21. Szegedi N, Széplaki G, Herczeg S, Tahin T, Salló Z, Nagy VK, Osztheimer I, Özcan EE, Merkely B, Gellér L. Repeat procedure is a new independent predictor of complications of atrial fibrillation ablation. Europace. 2019;21:732-737. doi: 10.1093/europace/euy326. IF:6.10

22. Ulus T, Okyay K, Kabul HK, Özcan EE, Özeke Ö, Altay H, Görenek B, Yıldırır A, Okutucu S, Tekin A. Turkish Society of Cardiology consensus paper on management of arrhythmia-induced cardiomyopathy. Anatol J Cardiol. 2019;21:98-106. doi: 10.14744/AnatolJCardiol.2019.60687. IF:1.11

23. Boriani G, Fauchier L, Aguinaga L, Beattie JM, Blomstrom Lundqvist C, Cohen A, Dan GA, Genovesi S, Israel C, Joung B, Kalarus Z, Lampert R, Malavasi VL, Mansourati J, Mont L, Potpara T, Thornton A, Lip GYH; ESC Scientific Document Group: Gorenek B, Marin F, Dagres N, Ozcan EE, Lenarczyk R, Crijns HJ, Guo Y, Proietti M, Sticherling C, Huang D, Daubert JP, Pokorney SD, Ortega MC, Chin A. European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS). Europace. 2019 Jan 1;21(1):7-8. doi: 10.1093/europace/euy110. IF:6.10

24. Özcan EE, Yilancioglu Y, Hasdemir C. Multipoint pacing controlled the electrical storm induced by cardiac resynchronization therapy. Europace. 2018;20:1749. doi: 10.1093/europace/euy096. IF: 5.23

25. Özcan EE, Dural M, Görenek B. Tips for management of arrhythmias in endocrine disorders from an European Heart Rhythm Association position paper. Anatol J Cardiol. 2018;20:241-245. IF:1.27

26. Colluoglu T, Tanriverdi Z, Unal B, Ozcan EE, Dursun H, Kaya D. The role of baseline and post-procedural frontal plane QRS-T angles for cardiac risk assessment in patients with acute STEMI. Ann Noninvasive Electrocardiol. 2018 Jun 6:e12558. doi: 10.1111/anec.12558. IF:1.56

27. Hasdemir C, Juang JJ, Kose S, Kocabas U, Orman MN, Payzin S, Sahin H, Celen C, Ozcan EE, Chen CJ, Gunduz R, Turan OE, Senol O, Burashnikov E, Antzelevitch C. Coexistence of atrioventricular accessory pathways and drug-induced type 1 Brugada pattern. Pacing Clin Electrophysiol. 2018 Jun 28. doi: 10.1111/pace.13414. IF:1.48

28. Özcan EE, Görenek B. Clinical implications from the European Heart Rhythm Association consensus document on antiarrhythmic drug therapy. Anatol J Cardiol. 2018 Jul;20(1):48-51. IF:1.27

29. Özcan EE, Öztürk A, Özel E, Senarslan Ö, Merkely B, Geller L. The impact of the left ventricular pacing polarity and localization during cardiac resynchronization therapy on depolarization and repolarization parameters. Anatol J Cardiol. 2018 Mar 21. doi: 10.14744/AnatolJCardiol.2018.62357. IF:1.27

30. Özcan EE, Görenek B. Lessons from the current European Heart Rhythm Association consensus document on screening for atrial fibrillation. Anatol J Cardiol. 2018;19:222-224. IF:1.27

31. Özcan EE, Görenek B. What we have learned from the European Heart Rhythm Association consensus document on device-detected subclinical atrial tachyarrhythmias. Anatol J Cardiol. 2018;19:137-139. IF:1.27

32. Osztheimer I, Szilágyi S, Pongor Z, Zima E, Molnár L, Tahin T, Özcan EE, Széplaki G, Merkely B, Gellér L. Minimal invasive right ventricular and atrial pacemaker lead repositioning as a first alternative is superior in avoiding pocket complications with passive fixation leads. J Interv Card Electrophysiol. 2017;49:33-38. IF:1.52

33. Kutyifa V, Vitali Serdoz L, Özcan EE, Balsam P, De Potter T. European Heart Rhythm Association Young Electrophysiology Community: introducing our National Ambassadors of Italy, Turkey, and Poland. Europace. 2017;19:856-857. IF: 5.23

34. Szili Torok T, DE Vries LJ, Özcan EE, Hasdemir C, Kis Z, Kardos A, Géczy T, Kovacs I, Benedek I, Oosterwerff E, Hendriks AA, Khan M, Yap SC. Disappearance of Idiopathic Outflow Tract Premature Ventricular Contractions After Catheter Ablation of Overt Accessory Pathways. J Cardiovasc Electrophysiol. 2017;28:78-84. IF:2.87

35. Özel E, Taştan A, Öztürk A, Özcan EE, Kilicaslan B, Özdogan Ö. Procedural and one-year clinical outcomes of bioresorbable vascular scaffolds for the treatment of chronic total occlusions: a single-centre experience. Cardiovasc J Afr. 2016;27:345-349. IF:0.93

36. Akinci G, Topaloglu H, Akinci B, Onay H, Karadeniz C, Ergul Y, Demir T, Ozcan EE, Altay C, Atik T, Garg A. Spectrum of clinical manifestations in two young Turkish patients with congenital generalized lipodystrophy type 4. Eur J Med Genet. 2016;59:320-4. IF:2.00

37. Széplaki G, Gellér L, Özcan EE, Tahin T, Kovács OM, Parázs N, Karády J, Maurovich-Horvat P, Szilágyi S, Osztheimer I, Tóth A, Merkely B. Respiratory gating algorithm helps to reconstruct more accurate electroanatomical maps during atrial fibrillation ablation performed under spontaneous respiration. J Interv Card Electrophysiol. 2016;46:153-9. IF:1.52

38. Tastan A, Ozturk A, Senarslan O, Ozel E, Uyar S, Ozcan EE, Kozan O. Comparison of two different techniques for balloon sizing in percutaneous mitral balloon valvuloplasty: which is preferable? Cardiovasc J Afr. 2016;27:147-151. IF:0.93

39. Özel E, Taştan A, Öztürk A, Özcan EE, Uyar S, Şenarslan Ö. What is better for predilatation in bioresorbable vascular scaffold implantation: a non-compliant or a compliant balloon? Anatol J Cardiol. 2016;16:244-9. IF: 0.76

40. Kosztin A, Kutyifa V, Nagy VK, Geller L, Zima E, Molnar L, Szilagyi S, Ozcan EE, Szeplaki G, Merkely B. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients. Europace. 2016;18:550-9. IF:3.6

41. Ozel E, Osztheimer I, Ozturk A, Gellér L, Ozcan EE. Percutaneous right atrial pacemaker lead repositioning using a regular deflectable ablation catheter. Postepy Kardiol Interwencyjnej. 2016;12:183-4.  IF:1.44

42. Özel E, Taştan A, Öztürk A, Özcan EE. Relationship between Sympathetic Overactivity and Left Ventricular Hypertrophy in Resistant Hypertension. Hellenic J Cardiol. 2015;56:501-6. IF:1.89

43. Alihanoglu YI, Yildiz BS, Özcan EE, Kilic DI, Kuru DS, Taskoylu O, Tanriverdi H, Kaftan HA, Evrengul H. Impaired coronary blood flow may be related to elevated homocysteine levels in patients with metabolic syndrome. Wien Klin Wochenschr. 2015 Nov;127(21-22):864-870. doi: 10.1007/s00508-015-0854-z. Epub 2015 Sep 16. Erratum in: Wien Klin Wochenschr. 2018 May 7 IF: 0.95

44. Taştan A, Özel E, Öztürk A, Uyar S, Özcan EE, Şenarslan Ö, Tavlı T. Comparison of floating wire and single wire techniques in right coronary ostial lesions in terms of procedural features and one-year clinical follow-up results. Anadolu Kardiyol Derg. 2015;15:830-5.  IF:0.7

45. Özcan EE, Szilagyi S, Sallo Z, Molnar L, Zima E, Szeplaki G, Osztheimer I, Öztürk A, Merkely B, Geller L. Comparison of the Effects of Epicardial and Endocardial Cardiac Resynchronization Therapy on Transmural Dispersion of Repolarization. Pacing Clin Electrophysiol. 2015;38:1099-105. IF: 1.1

46. Ozcan EE, Szeplaki G, Merkely B, Geller L. Isolation of persistent left superior vena cava during atrial fibrillation ablation. Indian Pacing Electrophysiol J. 2015;15:130-2.

47. Kutyifa V, Geller L, Bogyi P, Zima E, Aktas MK, Ozcan EE, Becker D, Nagy VK, Kosztin A, Szilagyi S, Merkely B. Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience. Eur J Heart Fail. 2014;16:1323-30. IF:6.5

48. Széplaki G, Ozcan EE, Osztheimer I, Tahin T, Merkely B, Gellér L. Ablation of the epicardial substrate in the right ventricular outflow tract in a patient with brugada syndrome refusing implantable cardioverter defibrillator therapy. Can J Cardiol. 2014;30:1249.e9-1249.e11. IF:3.9

49. Özcan EE, Szeplaki G, Tahin T, Osztheimer I, Szilagyi S, Apor A, Horvath PM, Vago H, Merkely B, Geller L. Impact of respiration gating on image integration guided atrial fibrillation ablation. Clin Res Cardiol. 2014;103:727-31. IF: 4.1

50. Öztürk A, Özcan EE, Özel E, Uyar S, Senaslan Ö. Medical treatment of an adult with uncorrected isolated interrupted aorta resulted in no complications after 4 years of follow-up. Am J Case Rep. 2014;15:330-2.

51. Ozel E, Oztürk A, Ozcan EE, Genç B. An extremely rare reason for failure of left sided pacemaker implantation. Case Rep Cardiol. 2014;2014:453071.

52. Özcan EE, Osztheimer I, Széplaki G, Merkely B, Gellér L. Successful ablation of atrioventricular nodal re-entrant tachycardia in a patient with interruption of inferior vena cava and azygos continuation. Can J Cardiol. 2013;29:1741. IF: 3.9

53. Ozcan EE, Széplaki G, Tahin T, Osztheimer I, Szilágyi S, Merkely B, Gellér L. When to go epicardially during ventricular tachycardia ablation? Role of surface electrocardiogram. Interv Med Appl Sci. 2013;5:182-5.

54. Ozcan EE, Szeplaki G, Osztheimer I, Tahin T, Geller L. Catheter ablation of electrical storm triggered by monomorphic ventricular ectopic beats after myocardial infarction. Anadolu Kardiyol Derg. 2013;13:595-7. IF: 0.7

55. Ozcan EE, Szeplaki G, Merkely B, Geller L. Non-reentrant atrioventricular nodal tachycardia. Clin Res Cardiol. 2013;102:383-6. IF: 4.1

56. Kozan O, Tengiz I, Ozcan EE, Ozpelit ME, Taştan A, Türk UO, Alioğlu E, Ercan E. The evaluation of hypertensive patients who are supposedly under control according to office blood pressure measurements with ambulatuar blood pressure monitoring: an observational prospective study in three big cities (AKB3IL study)]. Turk Kardiyol Dern Ars. 2012;40:481-90.

57. Evrengul H, Tanriverdi H, Kilic ID, Dursunoglu D, Ozcan EE, Kaftan A, Kilic M. Aortic stiffness and flow-mediated dilatation in normotensive offspring of parents with hypertension. Cardiol Young. 2012;22:451-6. IF:0.8

58. Özcan EE, Küçük A. Impact of severity of congenital heart diseases on university graduation rate among male patients.Turk Kardiyol Dern Ars. 2012;40:229-34.

59. Evrengul H, Ozcan EE, Turhan H, Ozturk A. Single coronary artery originating from the right sinus of Valsalva and hypoplastic left anterior descending artery: An extremely rare combination of congenital coronary artery anomalies. Exp Clin Cardiol. 2012;17:243-4. IF:0.7

60. Kozan O, Ozcan EE, Sancaktar O, Kabakcı G; Turkish investigators of the i-SEARCH study. The prevalence of microalbuminuria and relevant cardiovascular risk factors in Turkish hypertensive patients. Turk Kardiyol Dern Ars. 2011;39:635-45.

61. Evrengül H, Ozcan EE. Double-orifice mitral valve. Turk Kardiyol Dern Ars. 2011;39:625.

62. Ozcan EE, Guneri S, Akdeniz B, Akyildiz IZ, Senaslan O, Baris N, Aslan O, Badak O. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial. Am Heart J. 2007;154:539-44. IF: 4.5

Reset Filters

All Trainings From This Instructor

bottom of page